Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

A prospective nationwide study of drug-induced liver injury in Korea.

Suk KT, Kim DJ, Kim CH, Park SH, Yoon JH, Kim YS, Baik GH, Kim JB, Kweon YO, Kim BI, Kim SH, Kim IH, Kim JH, Nam SW, Paik YH, Suh JI, Sohn JH, Ahn BM, Um SH, Lee HJ, Cho M, Jang MK, Choi SK, Hwang SG, Sung HT, Choi JY, Han KH.

Am J Gastroenterol. 2012 Sep;107(9):1380-7. doi: 10.1038/ajg.2012.138. Epub 2012 Jun 26.

PMID:
22733303
2.

Drug-induced liver injury: present and future.

Suk KT, Kim DJ.

Clin Mol Hepatol. 2012 Sep;18(3):249-57. doi: 10.3350/cmh.2012.18.3.249. Epub 2012 Sep 25. Review.

3.

[Clinical and pathological features in 138 cases of drug-induced liver injury].

Lai RT, Wang H, Gui HL, Ye MZ, Dai WJ, Xiang XG, Zhao GD, Wang WJ, Xie Q.

Zhonghua Gan Zang Bing Za Zhi. 2012 Mar;20(3):185-9. doi: 10.3760/cma.j.issn.1007-3418.2012.03.009. Chinese.

PMID:
22475136
4.

Drug-induced liver injury.

Leise MD, Poterucha JJ, Talwalkar JA.

Mayo Clin Proc. 2014 Jan;89(1):95-106. doi: 10.1016/j.mayocp.2013.09.016. Review.

PMID:
24388027
5.

Drug-induced liver injury: A 2-year retrospective study of 1169 hospitalized patients in a single medical center.

Woo HJ, Kim HY, Choi ES, Cho YH, Kim Y, Lee JH, Jang E.

Phytomedicine. 2015 Dec 1;22(13):1201-5. doi: 10.1016/j.phymed.2015.10.002. Epub 2015 Oct 20.

PMID:
26598920
6.

Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.

Björnsson ES, Bergmann OM, Björnsson HK, Kvaran RB, Olafsson S.

Gastroenterology. 2013 Jun;144(7):1419-25, 1425.e1-3; quiz e19-20. doi: 10.1053/j.gastro.2013.02.006. Epub 2013 Feb 16.

PMID:
23419359
7.

Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.

Robles-Diaz M, Lucena MI, Kaplowitz N, Stephens C, Medina-Cáliz I, González-Jimenez A, Ulzurrun E, Gonzalez AF, Fernandez MC, Romero-Gómez M, Jimenez-Perez M, Bruguera M, Prieto M, Bessone F, Hernandez N, Arrese M, Andrade RJ; Spanish DILI Registry; SLatinDILI Network; Safer and Faster Evidence-based Translation Consortium.

Gastroenterology. 2014 Jul;147(1):109-118.e5. doi: 10.1053/j.gastro.2014.03.050. Epub 2014 Apr 1.

8.

Clinical Features of Drug-induced Liver Injury According to Etiology.

Lee BM, Lee WC, Jang JY, Ahn P, Kim JN, Jeong SW, Park EJ, Lee SH, Kim SG, Cha SW, Kim YS, Cho YD, Kim HS, Kim BS.

J Korean Med Sci. 2015 Dec;30(12):1815-20. doi: 10.3346/jkms.2015.30.12.1815. Epub 2015 Nov 30.

9.

RUCAM in Drug and Herb Induced Liver Injury: The Update.

Danan G, Teschke R.

Int J Mol Sci. 2015 Dec 24;17(1). pii: E14. doi: 10.3390/ijms17010014. Review.

10.

Systematic review of the incidence of herbal drug-induced liver injury in Korea.

Oh SJ, Cho JH, Son CG.

J Ethnopharmacol. 2015 Jan 15;159:253-6. doi: 10.1016/j.jep.2014.11.027. Epub 2014 Nov 24. Review.

PMID:
25460587
11.

Causality assessment of herb-induced liver injury using multidisciplinary approach and Roussel Uclaf Causality Assessment Method (RUCAM).

Nin Chau T, Cheung WI, Ngan T, Lin J, Lee KW, Tat Poon W, Leung VK, Mak T, Tse ML; Hong Kong Herb-Induced Liver Injury Network (HK-HILIN).

Clin Toxicol (Phila). 2011 Jan;49(1):34-9. doi: 10.3109/15563650.2010.537662. Epub 2010 Nov 29.

PMID:
21114414
12.
13.

Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method.

Rockey DC, Seeff LB, Rochon J, Freston J, Chalasani N, Bonacini M, Fontana RJ, Hayashi PH; US Drug-Induced Liver Injury Network.

Hepatology. 2010 Jun;51(6):2117-26. doi: 10.1002/hep.23577.

14.

Incidence of liver injury among cancer patients receiving chemotherapy in an integrated health system.

Ulcickas Yood M, Bortolini M, Casso D, Beck JG, Oliveria SA, Wells KE, Woodcroft KJ, Wang LI.

Pharmacoepidemiol Drug Saf. 2015 Apr;24(4):427-34. doi: 10.1002/pds.3757. Epub 2015 Feb 12.

PMID:
25683797
15.

Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?

Teschke R, Schulze J, Eickhoff A, Danan G.

Int J Mol Sci. 2017 Apr 11;18(4). pii: E803. doi: 10.3390/ijms18040803. Review.

16.

Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase.

Xu HM, Chen Y, Xu J, Zhou Q.

World J Gastroenterol. 2012 Nov 7;18(41):5972-8. doi: 10.3748/wjg.v18.i41.5972.

17.

[RUCAM scale-based diagnosis, clinical features and prognosis of 140 cases of drug-induced liver injury].

Hao K, Yu Y, He C, Wang M, Wang S, Li X.

Zhonghua Gan Zang Bing Za Zhi. 2014 Dec;22(12):938-41. doi: 10.3760/cma.j.issn.1007-3418.2014.12.012. Chinese.

PMID:
25654289
18.

Presentation of drug-induced liver injury in Singapore.

Wai CT.

Singapore Med J. 2006 Feb;47(2):116-20.

19.

Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic Model.

Lo Re V 3rd, Haynes K, Forde KA, Goldberg DS, Lewis JD, Carbonari DM, Leidl KB, Reddy KR, Nezamzadeh MS, Roy J, Sha D, Marks AR, De Boer J, Schneider JL, Strom BL, Corley DA.

Clin Gastroenterol Hepatol. 2015 Dec;13(13):2360-8. doi: 10.1016/j.cgh.2015.06.020. Epub 2015 Jun 27.

20.

Hepatobiliary and pancreatic: Comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients.

Zhu Y, Niu M, Chen J, Zou ZS, Ma ZJ, Liu SH, Wang RL, He TT, Song HB, Wang ZX, Pu SB, Ma X, Wang LF, Bai ZF, Zhao YL, Li YG, Wang JB, Xiao XH; Specialized Committee for Drug-Induced Liver Diseases, Division of Drug-Induced Diseases, Chinese Pharmacological Society.

J Gastroenterol Hepatol. 2016 Aug;31(8):1476-82. doi: 10.1111/jgh.13323.

PMID:
26896664

Supplemental Content

Support Center